Cite

HARVARD Citation

    Paciullo, F. et al. (2022). Pleiotropic effects of PCSK9-inhibition on hemostasis: Anti-PCSK9 reduce FVIII levels by enhancing LRP1 expression. Thrombosis research. pp. 170-172. [Online]. 
  
Back to record